Abstract
Licochalcone (LC), a major phenolic retrochalcone from licorice, has anti-inflammatory activity. This study investigated the effects of licochalcone A (LCA) and licochalcone E (LCE) on Liver X receptor-α (LXRα)-mediated lipogenic gene expression and the molecular mechanisms underlying those effects. LCA and LCE antagonized the ability of LXRα agonists (T0901317 or GW3965) to increase sterol regulatory element binding protein-1c (SREBP-1c) expression and thereby inhibited target gene expression (e.g., FAS and ACC) in HepG2 cells. Moreover, treatment with LCA and LCE impaired LXRα/RXRα-induced CYP7A1-LXRE-luciferase (CYP7A1) transactivation. The AMPK-Sirt1 signaling pathway is an important regulator of energy metabolism and, therefore, a potential therapeutic target for metabolic diseases, including hepatic steatosis. We found here that LCE increased AMPK phosphorylation and Sirt1 expression. We conclude that LC inhibits SREBP-1c-mediated hepatic lipogenesis via activation of the AMPK/Sirt1 signaling pathway.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jakobsson, T., Treuter, E., Gustafsson, J.Å. and Steffensen, K.R. (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol. Sci., 33, 394–404.
Akiyama, T.E., Sakai, S., Lambert, G., Nicol, C.J., Matsusue, K., Pimprale, S., Lee, Y.H., Ricote, M., Glass, C.K., Brewer, H.B. Jr. and Gonzalez, F.J. (2002) Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell Biol., 22, 2607–2619.
Schultz, J.R., Tu, H., Luk, A., Repa, J.J., Medina, J.C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D.J., Lustig, K.D. and Shan, B. (2000) Role of LXRs in control of lipogenesis. Genes Dev., 14, 2831–2838.
Repa, J.J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.M., Shimomura, I., Shan, B., Brown, M.S., Goldstein, J.L. and Mangelsdorf, D.J. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev., 14, 2819–2830.
Ferré, P. and Foufelle, F. (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Metab., 12 Suppl 2, 83–92.
Kim, J.K., Shin, E.K., Park, J.H., Kim, Y.H. and Park, J.H. (2010) Antitumor and antimetastatic effects of licochalcone A in mouse models. J. Mol. Med. (Berlin), 88, 829–838.
Chu, X., Ci, X., Wei, M., Yang, X., Cao, Q., Guan, M., Li, H., Deng, Y., Feng, H. and Deng, X. (2012) Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J. Agric. Food Chem., 60, 3947–3954.
Friis-Møller, A., Chen, M., Fuursted, K., Christensen, S.B. and Kharazmi, A. (2002) In vitro antimycobacterial and anti-legionella activity of licochalcone A from Chinese licorice roots. Planta Med., 68, 416–419.
Haraguchi, H., Ishikawa, H., Mizutani, K., Tamura, Y. and Kinoshita, T. (1998) Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem., 6, 339–347.
Yoon, G., Jung, Y.D. and Cheon, S.H. (2005) Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata. Chem. Pharm. Bull. (Tokyo), 53, 694–695.
Park, H.G., Bak, E.J., Woo, G.H., Kim, J.M., Quan, Z., Yoon, H.K., Cheon, S.H., Yoon, G., Yoo, Y.J., Na, Y. and Cha, J.H. (2012) Licochalcone E has an antidiabetic effect. J. Nutr. Biochem., 23, 759–767.
Lee, H.N., Cho, H.J., Lim do, Y., Kang, Y.H., Lee, K.W. and Park, J.H. (2013) Mechanisms by which licochalcone e exhibits potent anti-inflammatory properties: studies with phorbol ester-treated mouse skin and lipopolysaccharide-stimulated murine macrophages. Int. J. Mol. Sci., 14, 10926–10943.
Yoon, G., Kang, B.Y. and Cheon, S.H. (2007) Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflata. Arch. Pharmacal Res., 30, 313–316.
Quan, H.Y., Kim, S.J., Kim do, Y., Jo, H.K., Kim, G.W. and Chung, S.H. (2013) Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase. Fitoterapia, 86, 208–216.
Wang, Y., Liang, Y. and Vanhoutte, P.M. (2011) SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. FEBS Lett., 585, 986–994.
Cantó, C. and Auwerx, J. (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol., 20, 98–105.
Hou, X., Xu, S., Maitland-Toolan, K.A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T.J., Cohen, R.A. and Zang, M. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem., 283, 20015–20026.
Gomes, A.P., Duarte, F.V., Nunes, P., Hubbard, B.P., Teodoro, J.S., Varela, A.T., Jones, J.G., Sinclair, D.A., Palmeira, C.M. and Rolo, A.P. (2012) Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim. Biophys. Acta, 1822, 185–195.
Jin, S.H., Yang, J.H., Shin, B.Y., Seo, K., Shin, S.M., Cho, I.J. and Ki, S.H. (2013) Resveratrol inhibits LXRalpha-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Toxicol. Appl. Pharmacol., 271, 95–105.
Hwahng, S.H., Ki, S.H., Bae, E.J., Kim, H.E. and Kim, S.G. (2009) Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology, 49, 1913–1925.
Li, Y., Xu, S., Mihaylova, M.M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J.Y., Gao, B., Wierzbicki, M., Verbeuren, T.J., Shaw, R.J., Cohen, R.A. and Zang, M. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab., 13, 376–388.
Ponugoti, B., Kim, D.H., Xiao, Z., Smith, Z., Miao, J., Zang, M., Wu, S.Y., Chiang, C.M., Veenstra, T.D. and Kemper, J.K. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem., 285, 33959–33970.
Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R.A., Bugianesi, E. and Gastaldelli, A. (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients, 5, 1544–1560.
Ludwig, J., Viggiano, T.R., McGill, D.B. and Oh, B.J. (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc., 55, 434–438.
Yoshikawa, T., Shimano, H., Amemiya-Kudo, M., Yahagi, N., Hasty, A.H., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Kimura, S., Ishibashi, S. and Yamada, N. (2001) Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell Biol., 21, 2991–3000.
Chisholm, J.W., Hong, J., Mills, S.A. and Lawn, R.M. (2003) The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res., 44, 2039–2048.
Yap, F., Craddock, L. and Yang, J. (2011) Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int. J. Biol. Sci., 7, 645–650.
Schug, T.T. and Li, X. (2011) Sirtuin 1 in lipid metabolism and obesity. Ann. Med., 43, 198–211.
Hubbard, B.P. and Sinclair, D.A. (2014) Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol. Sci., 35, 146–154.
Li, X., Zhang, S., Blander, G., Tse, J.G., Krieger, M. and Guarente, L. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell, 28, 91–106.
Walker, A.K., Yang, F., Jiang, K., Ji, J.Y., Watts, J.L., Purushotham, A., Boss, O., Hirsch, M.L., Ribich, S., Smith, J.J., Israelian, K., Westphal, C.H., Rodgers, J.T., Shioda, T., Elson, S.L., Mulligan, P., Najafi-Shoushtari, H., Black, J.C., Thakur, J.K., Kadyk, L.C., Whetstine, J.R., Mostoslavsky, R., Puigserver, P., Li, X., Dyson, N.J., Hart, A.C. and Näär, A.M. (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev., 24, 1403–1417.
Brandauer, J., Vienberg, S.G., Andersen, M.A., Ringholm, S., Risis, S., Larsen, P.S., Kristensen, J.M., Frøsig, C., Leick, L., Fentz, J., Jørgensen, S., Kiens, B., Wojtaszewski, J.F., Richter, E.A., Zierath, J.R., Goodyear, L.J., Pilegaard, H. and Treebak, J.T. (2013) AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle. J. Physiol., 591, 5207–5220.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Han, J.Y., Park, S.H., Yang, J.H. et al. Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation. Toxicol Res. 30, 19–25 (2014). https://doi.org/10.5487/TR.2014.30.1.019
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2014.30.1.019